rs10844318

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001278464.2(DNM1L):​c.957A>G​(p.Thr319Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.135 in 1,612,406 control chromosomes in the GnomAD database, including 15,139 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.14 ( 1555 hom., cov: 32)
Exomes 𝑓: 0.13 ( 13584 hom. )

Consequence

DNM1L
NM_001278464.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.749

Publications

11 publications found
Variant links:
Genes affected
DNM1L (HGNC:2973): (dynamin 1 like) This gene encodes a member of the dynamin superfamily of GTPases. The encoded protein mediates mitochondrial and peroxisomal division, and is involved in developmentally regulated apoptosis and programmed necrosis. Dysfunction of this gene is implicated in several neurological disorders, including Alzheimer's disease. Mutations in this gene are associated with the autosomal dominant disorder, encephalopathy, lethal, due to defective mitochondrial and peroxisomal fission (EMPF). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jun 2013]
DNM1L Gene-Disease associations (from GenCC):
  • encephalopathy due to mitochondrial and peroxisomal fission defect
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1
    Inheritance: AD, AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • optic atrophy 5
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • autosomal dominant optic atrophy, classic form
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Leigh syndrome
    Inheritance: AR, AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 12-32722472-A-G is Benign according to our data. Variant chr12-32722472-A-G is described in ClinVar as Benign. ClinVar VariationId is 260168.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.749 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.166 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNM1LNM_001278464.2 linkc.957A>G p.Thr319Thr synonymous_variant Exon 10 of 21 ENST00000553257.6 NP_001265393.1 O00429-6B4DYR6
DNM1LNM_012062.5 linkc.918A>G p.Thr306Thr synonymous_variant Exon 9 of 20 ENST00000549701.6 NP_036192.2 O00429-1B4DYR6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNM1LENST00000553257.6 linkc.957A>G p.Thr319Thr synonymous_variant Exon 10 of 21 2 NM_001278464.2 ENSP00000449089.1 O00429-6
DNM1LENST00000549701.6 linkc.918A>G p.Thr306Thr synonymous_variant Exon 9 of 20 1 NM_012062.5 ENSP00000450399.1 O00429-1

Frequencies

GnomAD3 genomes
AF:
0.141
AC:
21495
AN:
152092
Hom.:
1551
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.169
Gnomad AMI
AF:
0.273
Gnomad AMR
AF:
0.122
Gnomad ASJ
AF:
0.161
Gnomad EAS
AF:
0.0735
Gnomad SAS
AF:
0.105
Gnomad FIN
AF:
0.0892
Gnomad MID
AF:
0.187
Gnomad NFE
AF:
0.141
Gnomad OTH
AF:
0.152
GnomAD2 exomes
AF:
0.123
AC:
30841
AN:
250954
AF XY:
0.125
show subpopulations
Gnomad AFR exome
AF:
0.171
Gnomad AMR exome
AF:
0.0779
Gnomad ASJ exome
AF:
0.168
Gnomad EAS exome
AF:
0.0769
Gnomad FIN exome
AF:
0.0970
Gnomad NFE exome
AF:
0.141
Gnomad OTH exome
AF:
0.135
GnomAD4 exome
AF:
0.134
AC:
195843
AN:
1460196
Hom.:
13584
Cov.:
32
AF XY:
0.134
AC XY:
97565
AN XY:
726412
show subpopulations
African (AFR)
AF:
0.175
AC:
5856
AN:
33430
American (AMR)
AF:
0.0838
AC:
3747
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.162
AC:
4242
AN:
26124
East Asian (EAS)
AF:
0.0708
AC:
2808
AN:
39648
South Asian (SAS)
AF:
0.112
AC:
9646
AN:
86208
European-Finnish (FIN)
AF:
0.100
AC:
5339
AN:
53366
Middle Eastern (MID)
AF:
0.176
AC:
888
AN:
5044
European-Non Finnish (NFE)
AF:
0.139
AC:
154925
AN:
1111382
Other (OTH)
AF:
0.139
AC:
8392
AN:
60272
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
8203
16406
24610
32813
41016
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5500
11000
16500
22000
27500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.141
AC:
21500
AN:
152210
Hom.:
1555
Cov.:
32
AF XY:
0.139
AC XY:
10335
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.169
AC:
7017
AN:
41520
American (AMR)
AF:
0.122
AC:
1866
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.161
AC:
557
AN:
3468
East Asian (EAS)
AF:
0.0737
AC:
382
AN:
5184
South Asian (SAS)
AF:
0.104
AC:
503
AN:
4820
European-Finnish (FIN)
AF:
0.0892
AC:
945
AN:
10594
Middle Eastern (MID)
AF:
0.187
AC:
55
AN:
294
European-Non Finnish (NFE)
AF:
0.141
AC:
9610
AN:
68016
Other (OTH)
AF:
0.150
AC:
317
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
960
1921
2881
3842
4802
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
238
476
714
952
1190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.140
Hom.:
1468
Bravo
AF:
0.146
Asia WGS
AF:
0.105
AC:
366
AN:
3476
EpiCase
AF:
0.149
EpiControl
AF:
0.154

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Feb 22, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Optic atrophy 5 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.57
CADD
Benign
6.6
DANN
Benign
0.73
PhyloP100
-0.75
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10844318; hg19: chr12-32875406; COSMIC: COSV56772893; COSMIC: COSV56772893; API